Biopharmaceutical research

SCHERING-PLOUGH is an innovation-driven, science-centered global healthcare company.

Through its own biopharmaceutical research and collaborations with partners, Schering- Plough creates therapies that help save and improve lives around the world. The company applies its research and development platform to human prescription and consumer products as well as to animal health products. In November 2007, Schering- Plough acquired Organon BioSciences, with its Organon human health and Intervet animal health businesses, marking a pivotal step in the company’s ongoing transformation.

Latest Issues

VyvaExperts25

Virtual
30th - 31st October 2025

NAMDET 2025 National Annual Conference

Wimbledon Football Stadium Conference Centre, Tooting London
12th November 2025

AfPP Regional Conference – Edinburgh

John McIntyre Conference Centre, The University of Edinburgh
22nd November 2025